Isradipine – Clinical Trial Results

Isradipine – Clinical Trial Results
The results of the STEADY-PD Phase III clinical trial results for Parkinson's have been released. The trial had been testing the blood pressure medication Isradipine for its ability to slow the progression of Parkinson's. The announced results are disappointing, suggesting that the treatment did not show any benefit for people with Parkinson's. This National Institute of Neurological Disorders and Stroke ... read more
Source: Published on 2019-05-07